Viatris Wins 2021 Global CPhI Pharma Award for Digital Innovation

Submitted by Kelly H. Zou, PStat®, Head of Global Medical Analytics and Real World Evidence, Viatris

Viatris recently won the Excellence in Pharma: Digital Innovation award and was a finalist for the Excellence in Pharma: Regulatory Procedures and Compliance award from CPhI Pharma, which recognizes a set of projects that harness real-world evidence (RWE) and artificial intelligence (AI) for regulatory use over a three-year period. RWE can be useful for patient centricity, medicine regulation, digital innovation via eHealth, and sophisticated algorithms such as machine learning and deep learning.

There were two components to Viatris winning the digital innovation award:

1. RWE/Digital/AI with peer-reviewed publications on RWE for regulatory purposes and innovation; RWE for noncommunicable diseases; AI, machine learning, and deep learning
2. A set of electronic survey studies for regulatory uses with associated publications that illustrated the importance, value, and applicability of such digital innovation

The Viatris team focused on patient-centric approaches to examine patients’ medication uses, treatment pattern and adherence, and journey.

The 18th CPhI Pharma Awards recognize the innovation and dedication of companies and individuals who are driving the pharmaceutical industry forward through their innovations, technologies, and strategies.